Rebeca Carrión-Marchante

An optimized MNK1b aptamer, apMNKQ2, and its potential use as a therapeutic agent in breast cancer

Celia Pinto‐Díez, Raquel Ferreras-Martín, Rebeca Carrión-Marchante et al. · Molecular Therapy — Nucleic Acids · 2022 · 13 citations · Full text

Potential Therapeutic Use of Aptamers against HAT1 in Lung Cancer

José Ignacio Klett-Mingo, Celia Pinto‐Díez, Julio Cambronero-Plaza et al. · Cancers · 2022 · 11 citations · Full text

DNA Aptamers against Vaccinia-Related Kinase (VRK) 1 Block Proliferation in MCF7 Breast Cancer Cells

Rebeca Carrión-Marchante, Valerio Frezza, Ana Salgado-Figueroa et al. · Pharmaceuticals · 2021 · 10 citations · Full text

Breast Oncology, Cancer-associated Virus, Receptor Tyrosine Kinase +14

FPR2 DNA Aptamers for Targeted Therapy of Wound Repair

María del Carmen de Arriba, Gerónimo Fernández, Esteban Chacón-Solano et al. · Journal of Investigative Dermatology · 2022 · 10 citations

Fpr2 Dna Aptamers, Molecular Biology, Wound Care +2